Receiving the COVID-19 vaccine and booster reduced preeclampsia risk by nearly 60% in pregnant patients with preexisting morbidities.

Children of mothers with pregestational or gestational diabetes face increased risk of delayed attainment of early developmental milestones.

Under guidance released Monday, the FDA said it may consider approving vape flavors such as mint, coffee, tea and spices like clove or cinnamon. But it will continue rejecting sweet or fruit-flavored ...

Postholiday weekdays are associated with a significantly increased incidence of out-of-hospital cardiac arrest.

Elevated perceived stress during and after pregnancy may contribute to higher blood pressure among patients with an adverse pregnancy outcome.

Vitamin D3 supplementation does not change the 4-week incidence of health care utilization or COVID-19-related outcomes among adults with newly diagnosed COVID-19 but may reduce the risk for long ...

Postlaminectomy syndrome after posterior lumbar fusion is associated with significantly increased long-term risk for major cardiac events.

The AHA predicts that total cardiovascular disease burden among US women will rise from 10.7% to 14.4% by 2050, driven by aging and diversity.

Among patients eligible for MBS, GLP-1 RA prescriptions increased from 2018 to 2025, while MBS use decreased beginning in 2023.

Implementation of an OPTN wait-time modification policy in 2023 was associated with increased kidney transplant rates among Black patients.

Poor childhood oral health is associated with an increased risk for atherosclerotic cardiovascular disease (ASCVD) in adulthood.

GLP-1 RAs for weight loss appear to be similarly effective among adults across ages, races, and starting weights.